BeOne Medicines to release Q3 2025 financial results November 6
BeOne Medicines Ltd. will release its unaudited financial results for the third quarter ended September 30, 2025, on Thursday, November 6, 2025. These results, prepared in accordance with U.S. Generally Accepted Accounting Principles, will be announced after trading hours of the Hong Kong Stock Exchange. The company’s audit committee is scheduled to review and approve these results on the same date.
Following the announcement, BeOne Medicines will host a conference call with its management at 8:00 a.m. U.S. Eastern Time (9:00 p.m. Hong Kong Time) on Thursday, November 6, 2025. The conference call will be webcast live and accessible via multiple links on the company’s investor relations websites, with an archived version also available. Participants are advised to register at least 15 minutes prior to the scheduled webcast.
The board of directors, as of October 22, 2025, includes John V. Oyler as chairman and executive director, Dr. Xiaodong Wang as non-executive director, and a diverse group of independent non-executive directors.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when BeiGene publishes news
Free account required • Unsubscribe anytime